SA

Salman Ahmad

Active Director Director DIN 06590291
DIN 06590291 First appointment Jun 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2013
Shareholding value •••• Premium profile

About Salman Ahmad

Data last updated:

Salman Ahmad is a Director at Aliento Life Sciences Private Limited (since 2013). The company operates in Healthcare. Aliento Life Sciences Private Limited reported revenue of ₹6.5 Lakh (FY 2025).

DIN 06590291
Primary Designation Director
Industry Healthcare
First Appointment 14 Jun 2013
Oldest Company Age 13 yrs
Largest company Aliento Life Sciences Private Limited · ₹6.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jun 20132013₹6.5 Lakh (FY 2025)Active

Board colleagues of Salman Ahmad

NameDINCompanyDesignation
Varisha08243209Aliento Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aliento Life Sciences Private Limited
Premium access

Shareholding and investment profile for Salman Ahmad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Salman Ahmad

Salman Ahmad currently holds 1 directorship: Aliento Life Sciences Private Limited (Director, since 14 Jun 2013, revenue ₹6.5 Lakh (FY 2025)).

Salman Ahmad was first appointed on 14 Jun 2013 as Director at Aliento Life Sciences Private Limited.

The current boards of Salman Ahmad's companies include Varisha (Aliento Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available